搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
2 天
Buy Rating Affirmed on Oncolytics Biotech Following Promising Pelareorep Clinical Data
Canaccord Genuity analyst John Newman has maintained their bullish stance on ONCY stock, giving a Buy rating yesterday. John Newman has given ...
2 天
Buy Rating Affirmed for Oncolytics Biotech on Strong Phase 2 Results and Commercial Potential
Oncolytics Biotech (ONCY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
3 天
Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Targeted Oncology
3 天
Pelareorep Plus Paclitaxel Extends Survival in HR+/HER2– Breast Cancer
The phase 2 BRACELET-1 trial demonstrated that the combination of pelareorep and paclitaxel significantly improved outcomes ...
standardmedia.co.ke
4 天
Managing respiratory diseases in poultry
dusty chicken house or barn can cause persistent irritation of the respiratory airways leading to coughing sneezing rales and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈